Onderneming Lannett Company, Inc. Nyse MKT
Aandelen
LCI
US5160121019
Farmaceutische producten
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Timothy Crew
CEO | Chief Executive Officer | 63 | 02-01-18 |
Kristie Stephens
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-99 |
Michael Block
PRN | Corporate Officer/Principal | - | 01-01-12 |
Corporate Officer/Principal | 65 | 07-05-18 | |
Grant Brock
PRN | Corporate Officer/Principal | - | 01-02-18 |
Samuel Israel
LAW | General Counsel | 63 | 17-07-17 |
John Abt
PRN | Corporate Officer/Principal | 59 | 30-03-15 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Todd Clegg
BRD | Director/Board Member | - | - |
Jeffrey Goldberg
CHM | Chairman | - | 16-06-23 |
Jason Shandell
BRD | Director/Board Member | 50 | 16-06-23 |
Timothy Crew
CEO | Chief Executive Officer | 63 | 02-01-18 |
James Bauersmith
BRD | Director/Board Member | - | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 11 218 128 | 9 231 253 ( 82,29 %) | 437 941 ( 3,904 %) | 82,29 % |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+21,41% | 43,48 mld. | |
+20,67% | 22,65 mld. | |
+14,56% | 14,73 mld. | |
+14,21% | 13,79 mld. | |
+48,11% | 12,04 mld. | |
-8,37% | 7,08 mld. | |
-0,05% | 6,79 mld. | |
-8,87% | 5,73 mld. | |
+11,75% | 5,47 mld. |